AI Terminal
GELION PLC
Share Issue/Capital Change • Jan 29, 2024
7666_rns_2024-01-29_1be2e998-c6ea-40aa-a639-23113b3b17ba.html
Share Issue/Capital Change
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 1175B
Gelion PLC
29 January 2024
Gelion plc
("Gelion" or the "Company")
Block Admission Return
The Company provides the following update in accordance with Schedule Six of the AIM Rules for Companies regarding its existing block listing arrangements:
| a | Name of company | Gelion plc |
| b | Name of scheme | Gelion plc scheme: Shares Existing Share Option Plan 8,100,000 |
| c | Period of return (from/ to) | 26 July 2023 to 26 January 2024 |
| d | Number and Class of Securities not issued at the start of the period under the scheme | 7,914,000 ordinary shares of 0.1p each |
| e | Additional listing | Nil |
| f | Number of securities issued under the scheme during the period | Shares Existing Share Option Plan 12,144 |
| g | Balance under the scheme of securities not yet issued at the end of the period | Shares Existing Share Option Plan 7,901,856 |
| h | Number and class of securities originally admitted and the date of admission | 8,100,000 ordinary shares of 0.1p each |
| i | Contact name - Company Telephone number Contact name - Cavendish Capital Markets Limited Telephone number |
Amit Gupta 020 7749 2640 Neil McDonald 020 7220 0500 |
CONTACTS
| Gelion plc John Wood, CEO Amit Gupta, CFO Thomas Maschmeyer, Founder and Principal Technology Advisor |
via Alma |
| Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker) | +44 207 220 0500 |
| Neil McDonald (Corporate Finance) Seamus Fricker (Corporate Finance) Fergus Sullivan (Corporate Finance) Leif Powis (Sales) |
|
| Alma Strategic Communications (Financial PR Adviser) Justine James Hannah Campbell Will Ellis Hancock |
+44 20 3405 0205 [email protected] |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
BLRSEIFWMELSESF